Articles On Holista CollTech (ASX:HCT)

The ASX fell 0.4% after Wall Street was hit by a massive sell-off overnight Wage data shows ‘real wage’ decline in 2022 is the worst in recorded history Toys’R’Us wins the day by offering to buy back its own beleaguered shares   And that’...

ASX slumps even lower after lunch to end the day down around 0.5% China’s demands for the return of “weather balloon” debris met with hearty Pentagon chuckles Terramin’s bid to reopen a sub-winery mine shut down by the SA government   It’...

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

Audiences outraged over the benchmark’s “lacklustre, mediocre performance” today Standout winner Riedel Resources ends the day up by 50% on awesome assays FTX team drowning in irony as ‘hackers’ make off with more than $500 million   The...

Adelong Gold cranks out a 143% gain for the day ASX 200 benchmark feel by 0.13% by the close of play China’s December Quarter GDP figures are… let’s just say ‘questionably good at best’   We’ve just got time for a super-quick, lightning-...

Good news is bad news for the US economy Aussie benchmark goes deep into a pre-Christmas shame spiral Ho ho oh s%#$! What just happened?   The Closing Jingle Bell has rung, so that’s it until after Christmas for 2022! What a pity today’s...

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

Small caps up 0.86% while global markets wait for US midterm election results  Aussies have hit a record 1 million side hustles as the cost of living rises ReNu Energy nabs $100m investment from superannuation fund for green hydrogen proj...

We take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks from 2021 have gained since listing We also look at the best and worst performing ASX stocks over the past month   There were 191 ASX IPOs in...

Highlights Holista Colltech specialises in health and wellness solutions developed using a blend of the best of nature and science. Today, Holista has emerged as a strong player in the US$4.4 trillion global health and wellness industr...

ShareCafeWebinar Recap – TD1, MYL, C1X & HCT Catch up on the full webinar presentations from TALi (ASX: TD1), Mallee Resources (ASX: MYL), Cosmos Exploration (ASX: C1X) & Holista Colltech (ASX: HCT) Webinar Recap – TD1, MYL, C1X &a...

ShareCafeHolista Colltech (ASX: HCT) – Webinar Presentation Dr Rajen Manicka – Chairman and CEO – Holista is dedicated to delivering first-class natural ingredients and wellness products, and leads in research on herbs and food ingredients...

The ASX 200 is pretty flat, small caps up circa 0.5%  Materials and energy dragging locally Alibaba reports tonight: analysts predicting 30 thieves, down from previous high of 40   Around lunchtime, the major banks started passing on the...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Emerging markets index closes 2.3% lower ASX200 pretty flat, maybe ahead by 0.1% March Qtr GDP rises 0.8%   The Emerging Companies Index has got a lithium leak. We don’t where, we don’t know why. It was down more than 2.7% and has kinda...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Emerging markets index up 0.5% ASX200 1% lower Belararox (ASX:BRX) rocks    The ASX Emerging Companies (XEC) Index was trading 0.6% higher after lunch to the exact degree the ASX200 (XJO) was not, 0.6% weaker. At the close the small cap...

XEC rises like a stubborn mule, up 0.5% XJO wobbles, equivocates somehow ends 0.2% higher Galileo Mining (ASX:GAL) gains circa 200%   Choppy trade – oh yes – but with Galileo Mining (ASX:GAL) coming out swinging on Wednesday morning, tha...

Central Banks have their fingers on the fun button this week, and the markets are pricing in the big push. The Emerging Companies Index (XEC) has been sunk on day dot, down 2.3%. The S&P/ASX 200 index was down 1.2% at 4.15pm, with this...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

Holista Colltech’s (HCT) subsidiary, Holista Biotech, receives its first commercial order from Country Farms for its food ingredients Country Farms has placed a $43,000 order for Holista’s low glycaemic index (GI) food ingredient, GI Lite...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

The ASX Emerging Companies (XEC) index is busting out after a three-session losing streak that felt like ten days. I should know, I spent a week in Canberra one afternoon when I was about 15. Anyway, the index for sensational small caps is...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

Minerals260 (ASX:MI6), a spinoff from Liontown Resources (ASX:LTR), enjoyed a positive debut despite the ASX finishing down again. The ASX 200 retreated 0.26% to close at 7,821 points with all sectors in the red except consumer staples and...

Holista Colltech’s (HCT) subsidiary signs a non-binding collaboration term sheet with Country Farms Owned by Malaysian conglomerate Berjaya Corporation Berhad, Country Farms operates several franchises of international brands in Malaysia...

The ASX retreated again as angst over inflation and the withdrawal of stimulus continued to weigh on global markets. The ASX 200 closed at 7,300 – 0.28% lower than Friday’s close. Tech was the biggest laggard, losing nearly 3% but energy an...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

The ASX 200 closed at 7,488 points which was 0.04% down from yesterday but up 0.37% from last Friday. The ASX Emerging Companies Index lost 0.57% to close at 2,285 points. The best sector was industrials which gained 1.07%. Tech and consume...

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

The ASX had another positive day but, unlike yesterday, held momentum to close at an all time high. The ASX 200 closed at 7,511 points which was an 0.11% gain although the ASX Emerging Companies Index fell 0.63% to 2,226 points. The top sec...

An ASX-listed company, together with its chief executive, has been accused of spruiking false COVID-killing claims about its products. The Australian Securities and Investments Commission (ASIC) is suing Holista Colltech Limited (ASX: HCT)...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

The ASX rebounded from yesterday’s losses but short of an all time high. The ASX 200 closed at 7,503 points, 0.38% up from yesterday but 6 points behind its intraday high. Meanwhile the ASX Emerging Companies Index gained 0.63% at 2,240 poi...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

The ASX begun the week in positive territory with tech, and energy stocks both gaining over 1 per cent. The ASX 200 closed at 7,024 points, 0.13 per cent higher than Friday’s close. Meanwhile, the ASX Emerging Companies Index surged 1.46 pe...

Friday, and the week ended pretty much the way it began, with loopy comments from Elon Musk diverting everyone’s attention away from real life. BNPLs failed to recover from yesterday’s robust inflation expectations out of the US, and the ma...

The S&P/ASX200 closed lower on Thursday, dropping -62.20 points or -0.88% to 6982.70. However, some stocks gained substantially. Among top gainers were Whitehaven Coal Limited (ASX:WHC) that clocked 5.72% gains, GrainCorp Limited (ASX:...

Perth-based natural wellness company, Holista CollTech (ASX:HTC) is about to market its ovine (sheep) collagen into China. The company’s subsidiary, Holista Biotech, has just announced an exclusive distribution partnership with Malaysia-bas...